Enzyme preparation. The purified K-sialidase preparations, ranging in potency from 200 to 500 units per mg, were made by the method described in the preceding report, which also gives the details of the assay procedure (4) . Sialyllactose, with a purity of 16.4%, was prepared by the method described by French and Ada (3) . Some preparations were purchased from Sigma Chemical Co. (St. Louis, Mo.).
Antisera against K-sialidase were made in rabbits as follows. Rabbits were injected with 10 mg of Ksialidase incorporated in 1.0 ml of 0.85% saline intravenously at weekly intervals for 7 weeks. Bleedings were made 2 weeks after the last injection and the anti-K-sialidase titer was measured. Animals of high titer were bled and the sera were pooled. The sera were inactivated by incubating in a water bath at 56 C for 30 min.
Determination of the Km values of K-sialidase. The Km values were determined in the reaction system containing: 250 units of K-sialidase, 0.01 M CaC12, and serial twofold graded amounts of substrate; the total volume was made up to 0.5 ml with an 0.1 M acetate buffer at pH 5.5. The reaction mixtures were put into stoppered tubes and incubated at 37 C for 20 min. After incubation, the enzymatic activity was stopped by addition of the periodate reagent, which is the first step of the method of Aminoff (1) for the determination of released sialic acid.
Determination of the anti-K-sialidase titer ofserum. Serial twofold dilutions of sera, beginning at 1:4, were prepared in saline, and 0.1 ml of each dilution was put into two series of stoppered tubes; to each tube were added 80 units of K-sialidase in 0.1 ml of saline. The tubes were incubated at 37 C for 30 min. After incubation, the following materials were added to each tube of one series: 1 mg of bovine submaxillary mucin in 0.1 ml of saline and 0.1 ml of 0.5 M acetate buffer (pH 5.5) containing 0.05 M CaC12; the total volume was brought to 0.5 ml with distilled water. The same materials, except for substrate, were added to another series of the tubes. The two series of tubes were incubated for 90 min, and the released sialic acid was determined by the method of Aminoff (1). For each tube in the first series, the amount of sialic acid obtained was subtracted from the corresponding figure obtained with the second series containing the same amount of serum and K-sialidase, but not substrate. The anti-K-sialidase titer of serum was expressed as reciprocal of the serum dilution which inhibits the enzymatic activity of a definite amount of K-sialidase to the extent of 50%. Details of the procedure are given in Results. Vibrio cholerae sialidase was purchased from Takeda Pharmaceutical Co., Tokyo, Japan. The preparation was sealed in a lyoph- 
RESULTS
Kinetic study. Experiments were carried out with the reaction system containing 250 units of K-sialidase and twofold graded amounts of substrates. The Km values of K-sialidase for sialyllactose and bovine submaxillary mucin were estimated, from the Lineweaver-Burk plot (5), to be 0.9 and 0.17 mm ( Fig. 1 and 2 ). In the case of bovine submaxillary mucin, it was assumed that 1 mole of sialic acid was released from 1 mole of bovine submaxillary mucin.
Immunological study. Effect of antisera against the activity of K-sialidase was examined. Effect of serum at different concentrations was expressed in terms of the formula (2): log x = K log y/(l -y) where x represents reciprocal of dilution of antiserum; K is constant; and y represents the degree of specific activity of enzyme as a fraction of 1, taking 1 as the activity of enzyme in the absence of antiserum. A straightline relationship was observed (Fig. 3) , and 50% inhibition titer of antiserum was obtained by reading the intercepting point of the plot line with the ordinate, indicating that the value of y is 0.5.
With this procedure, the anti-K-sialidase titer was determined on human sera of various diseases. Table 1 a The sera were taken at random from various patients whose sera were taken against antistreptolysin 0 titration. The anti-K-sialidase titer was determined as described. anti-K-sialidase activity of various titers ranging from 4 to 128. Table 2 shows the results obtained with the patients who had had scarlet fever. Some patients showed definite rise in anti-streptolysin O titer, but none of them showed any change in anti-K-sialidase titer. No evidence supporting correlative relationship between antistreptolysin O titer and anti-K-sialidase titer was observed.
Effect of anti-K-sialidase sera upon Vibrio cholerae sialidase was examined under the same conditions as described above, except that each reaction mixture contained 47 units of Vibrio cholerae sialidase. Table 3 shows that rabbit and human anti-K-sialidase sera had scarcely any effect on the Vibrio cholerae sialidase. In so far as we have examined, no human serum had inhibitory activity against Vibrio cholerae sialidase. It may be reasonable to assume that the anti-K-sialidase activity of human sera is specific for K-sialidase.
DISCUSSION
The Km values of K-sialidase were determined for two substrates. The value of 0.9 mm obtained with sialyllactose is in close agreement with that of 1.2 mm reported by Ada and French (3) on Vibrio cholerae sialidase, applying sialyllactose as substrate.
So far we have examined no other strain which produced the same enzyme as strain 6646, but anti-K-sialidase activity was found widely in human sera. In general, enzymes produced by streptococcus are not usually confined to one group, so it seems promising to find serologically a The value of the reaction mixture without anti-K-sialidase serum was used as control.
bObtained from the rabbits immunized with K-sialidase.
c Obtained from a patient with scarlet fever.
identical K-sialidase in streptococcus strains of other groups. At present, we cannot conclude that anti-K-sialidase activity of human sera may be ascribed to group K streptococcus. Group K streptococcus is known as an oral bacterium, so it is conceivable that K-sialidase may be incorporated into the human body by many means. In regard to human sera, anti-Ksialidase titer had no correlation with the antistreptolysin 0 titer, and sera from patients who had had scarlet fever did not show any change in the anti-K-sialidase titer.
It has been reported that mucoproteins in human and animal sera release sialic acid under the action of sialidase (7) . The amounts of sialic acid released from sera change according to the conditions and kinds of animals from which the sera were drawn (7) . We have applied the method described in Methods and Materials to avoid the disturbance caused by the bound sialic acid in sera.
